Periprosthetic osteolysis: Pathophysiology and medical management

Seminars in Arthroplasty JSES

Volumn 13, Issue 4, 2002, Pages 238-254

  Illgen II, Richard ^a,b,c   Shanbhag, Arun ^a,b,c   Jacobs, Joshua ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ATORVASTATIN; BAFILOMYCIN A1; BISPHOSPHONIC ACID DERIVATIVE; CELECOXIB; CHROMIUM; COBALT; COLLAGENASE; ENDOTOXIN; ETANERCEPT; GELATINASE; HYPOCHOLESTEROLEMIC AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; MEVALONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOPROTEGERIN; PENTOXIFYLLINE; POLY(METHYL METHACRYLATE); POLYETHYLENE; PROSTAGLANDIN E2; PROTON PUMP INHIBITOR; TITANIUM; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG; VASCULOTROPIN ANTIBODY;

ARM PROSTHESIS; BACTERIAL CELL WALL; BONE DEFECT; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CYTOKINE RELEASE; DRUG EFFECT; FOLLOW UP; GENE THERAPY; HOST RESISTANCE; HUMAN; IN VITRO STUDY; NONHUMAN; OSTEOLYSIS; PARTICLE SIZE; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROSTHESIS FAILURE; PROSTHESIS LOOSENING; REOPERATION; REVIEW; SURVIVAL; TASK PERFORMANCE; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

EID: 0036822846     PISSN: 10454527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (165)

1. Kiratli BJ, Checovich MM, McBeath AA, et al. Measurement of bone mineral density by dual-energy x-ray absorptiometry in patients with the Wisconsin hip, an uncemented femoral stem. J Arthroplasty 11:184-193, 1996
2. Harris WH: The problem is osteolysis. Clin Orthop 311:46-53, 1995
3. Peters PC Jr, Engh GA, Dwyer KA, et al: Osteolysis after total knee arthroplasty without cement. J Bone Joint Surg Am 74:864-876, 1992
4. Schmalzried TP, Callaghan JJ: Wear in total hip and knee replacements. J Bone Joint Surg Am 81:115-136, 1999
5. Gill DR, Morrey BF: The Coonrad-Morrey total elbow arthroplasty in patients who have rheumatoid arthritis. A ten to fifteen-year follow-up study. J Bone Joint Surg Am 80:1327-1335, 1998
6. Sanchez-Sotelo J, Wright TW, O'Driscoll SW, et al: Radiographic assessment of uncemented humeral components in total shoulder arthroplasty. J Arthroplasty 16: 180-187, 2001
7. Sperling JW, Cofield RH, Rowland CM: Neer hemiarthroplasty and Neer total shoulder arthroplasty in patients fifty years old or less. Long-term results. J Bone Joint Surg Am 80:464-473, 1998
8. Engh GA, Ammeen DJ: Periprosthetic osteolysis with total knee arthroplasty. Instr Course Lect 50:391-398, 2001
9. Hall MJ, Popovic JR: 1998 summary: National hospital discharge survey. Vital Health Stat 316:1-17, 2000
10. Malchau H, Herberts P, Ahnfelt L: Prognosis of total hip replacement in Sweden. Follow-up of 92,675 operations performed 1978-1990. Acta Orthop Scand 64: 497-506, 1993
11. Garellick G, Malchau H, Herberts P: Survival of hip replacements. A comparison of a randomized trial and a registry. Clin Orthop 375:157-167, 2000
12. Font-Rodriguez DE, Scuderi GR, Insall JN: Survivorship of cemented total knee arthroplasty. Clin Orthop 345: 79-86, 1997
13. Schai PA, Thornhill TS, Scott RD: Total knee arthroplasty with the PFC system. Results at a minimum of ten years and survivorship analysis. J Bone Joint Surg Br 80:850-858, 1998
14. van Loon CJ, Wisse MA, de Waal M, et al: The kinematic total knee arthroplasty. A 10- to 15-year follow-up and survival analysis. Arch Orthop Trauma Surg 120: 48-52, 2000
15. Clatworthy MG, Ballance J, Brick GW, et al: The use of structural allograft for uncontained defects in revision total knee arthroplasty. A minimum five-year review. J Bone Joint Surg Am 83:404-411, 2001
16. Stiehl JB, Saluja R, Diener T: Reconstruction of major column defects and pelvic discontinuity in revision total hip arthroplasty. J Arthroplasty 15:849-857, 2000
17. Haddad FS, Garbuz DS, Masri BA, et al: Structural proximal femoral allografts for failed total hip replacements: A minimum review of five years. J Bone Joint Surg Br 82:830-836, 2000
18. Goldring SR, Schiller AL, Roelke M, et al: The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am 65:575-584, 1983
19. Willert HG: Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res 11:157-164, 1977
20. Harris WH, Schiller AL, Scholler JM, et al: Extensive localized bone resorption in the femur following total hip replacement. J Bone Joint Surg Am 58:612-618, 1976
21. Shanbhag AS, Jacobs JJ, Glant TT, et al: Composition and morphology of wear debris in failed uncemented total hip replacement. J Bone Joint Surg Br 76:60-67, 1994
22. Shanbhag AS, Jacobs JJ, Black J, et al: Macrophage/particle interactions: Effect of size, composition and surface area. J Biomed Mater Res 28:81-90, 1994
23. Archibeck M, Jacobs J, Roebuch K, et al: The basic science of periprosthetic osteolysis. Instr Course Lect 50:185-195, 2001
24. Kim KJ, Rubash HE, Wilson SC, et al: A histologic and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin Orthop 287:142-152, 1993
25. Horikoshi M, Macaulay W, Booth RE, et al: Comparison of interface membranes obtained from failed cemented and cementless hip and knee prostheses. Clin Orthop 309:69-87, 1994
26. Shanbhag AS, Bailey HO, Hwang DS, et al: Quantitative analysis of ultrahigh molecular weight polyethylene (UHMWPE) wear debris associated with total knee replacements. J Biomed Mater Res 53:100-110, 2000
27. Schmalzried TP, Jasty MJ, Rosenberg AE, et al: Polyethylene wear debris and tissue reactions in knee as compared to hip replacement prostheses. J Appl Biomat 5:185-190, 1994
28. Goodman SB, Chin RC, Chiou SS, et al: A clinical-pathologic-biochemical study of the membrane surrounding loosened and nonloosened total hip arthroplasties. Clin Orthop 244:182-187, 1989
29. Kobori M, Kamisato S, Yoshida M, et al: Revision of failed metal-backed patellar component of Miller/Galante-I total knee prosthesis. J Orthop Sci 5:436-438, 2000
30. Livingston BJ, Chmell MJ, Spector M, et al: Complications of total hip arthroplasty associated with the use of an acetabular component with a Hylamer liner. J Bone Joint Surg Am 79:1529-1538, 1997
31. Black J: Editorial: Does corrosion matter? J Bone Joint Surg Br 70:517-520, 1988
32. Gilbert JL, Buckley CA, Jacobs JJ: In vivo corrosion of modular hip prosthesis components in mixed and similar metal combinations. The effect of crevice, stress, motion, and alloy coupling. J Biomed Mater Res 27: 1533-1544, 1993
33. Goldring SR, Jasty MJ, Roelke MS, et al: Formation of a synovial-like membrane at the bone-cement interface. Its role in bone resorption and implant loosening after total hip replacement. Arthritis Rheum 29:836-841, 1986
34. Urban RM, Jacobs JJ, Gilbert JL, et al: Migration of corrosion products from modular hip prostheses. Particle microanalysis and histopathological findings. J Bone Joint Surg Am 76:1345-1359, 1994
35. Schmalzried TP, Jasty M, Harris WH: Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear and debris and the concept of the effective joint space. J Bone Joint Surg Am 74:849-863, 1992
36. Jacobs JJ, Sumner DR, Galante JO: Mechanisms of bone loss associated with total hip replacement. Orthop Clin North Am 24:583-590, 1993
37. Campbell P, McKellop J, Park SH, et al: The clinical wear performance of modern generation metal-on-metal THRs: An implant retrieval study. J Arthroplasty (in press)
38. Goodman SB, Ueie P, Song Y, et al: Cellular profile and cytokine production at prosthetic interfaces. J Bone Joint Surg Br 80:531-539, 1998
39. Jiranek WA, Machado M, Jasty M, et al: Production of cytokines around loosened cemented acetabular components: Analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg Am 75:863-879, 1993
40. Santavirta S, Sorsa T, Konttinen Y, et al: Role of mesenchymal collagenase in the loosening of total hip prosthesis. Clin Orthop 290:206-215, 1993
41. Shanbhag AS, Jacobs JJ, Black J, et al: Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty. J Arthroplasty 10:498-506, 1995
42. Wright T, Goodman S: Implant wear in total joint replacement: Clinical and biologic issues, material and design consideration. Rosemont, IL, American Academy of Orthopaedic Surgery, 2001, pp 61-85
43. Wright T, Goodman S: Implant wear in total joint replacement: Clinical and biologic issues, material and design consideration. Rosemont, IL, American Academy of Orthopaedic Surgery, 2001, pp 86-105
44. Green TR, Fisher J, Stone M, et al: Polyethylene particles of a "critical size" are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 19: 2297-2302, 1998
45. North RJ: The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection. J Exp Med 132:521-534, 1970
46. Tabata Y, Idada Y: Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 9:356-362, 1988
47. Horowitz SM, Doty SB, Lane JM, et al: Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption. J Bone Joint Surg Am 75:802-813, 1993
48. Catelas I, Huk OL, Petit A, et al: Flow cytometric analysis of macrophage response to ceramic and polyethylene particles: Effects of size, concentration, and composition. J Biomed Mater Res 41:600-607, 1998
49. Campbell P, Ma S, Yeom B, et al: Isolation of predominantly submicron-sized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res 29:127-131, 1995
50. Maloney WJ, Smith RL, Schmalzried TP, et al: Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg Am 77:1301-1310, 1995
51. Margevicius KJ, Bauer TW, McMahon JT, et al: Isolation and characterization of debris in membranes around total joint prostheses. J Bone Joint Surg Am 76:1664-1675, 1994
52. Hirakawa K, Bauer TW, Stulberg BN, et al: Comparison and quantitation of wear debris of failed total hip and total knee arthroplasty. J Biomed Mater Res 31:257-263, 1996
53. Schmalzried TP, Jasty M, Rosenberg A, et al: Polyethylene wear debris and tissue reactions in knee as compared to hip replacement prostheses. J Appl Biomater 5:185-190, 1994
54. Sochart DH: Relationship of acetabular wear to osteolysis and loosening in total hip arthroplasty. J Orthop 363:135-150, 1999
55. Dowd JE, Sychterz CJ, Young AM, et al: Characterization of long-term femoral-head-penetration rates: Association with and prediction of osteolysis. J Bone Joint Surg Am 82:1102-1107, 2000
56. Catelas I, Petit A, Zukor DJ, et al: Induction of macrophage apoptosis by ceramic and polyethylene particles in vitro. Biomaterials 20:625-630, 1999
57. Kobayashi A, Freeman MA, Bonfield W, et al: Number of polyethylene particles and osteolysis in total joint replacements: A quantitive study using a tissue-digestion method. J Bone Joint Surg Br 79:844-848, 1997
58. Rader CP, Sterner T, Jakob F, et al: Cytokine response of human macrophage-like cells after contact with polyethylene and pure titanium particles. J Arthroplasty 14:840-848, 1999
59. Gonzalez O, Smith RL, Goodman SB: Effect of size, concentration, surface area, and volume of polymethylmethacrylate particles on human macrophages in vitro. J Biomed Mater Res 30:464-473, 1996
60. Rai T: The toxicity of metals used in orthopaedic prostheses: An experimental study using cultured human synovial fibroblasts. J Bone Joint Surg Br 63:434-440, 1981
61. Haynes DR, Rogers SD, Hay S, et al: The difference in toxicity and release of bone-resorbing mediators induced by titanium and cobalt-chromium-alloy wear particles. J Bone Joint Surg Am 75:825-834, 1993
62. Maloney WJ, Smith RL, Castro F, et al: Fibroblast response to metallic debris in vitro. Enzyme induction, cell proliferation, and toxicity. J Bone Joint Surg Am 75-A:835-844, 1993
63. Haynes DR, Boyle SJ, Rogers SD, et al: Variation in cytokines induced by particles from different prosthetic materials. Clin Orthop 352:223-230, 1998
64. Shanbhag AS, Jacobs JJ, Black J, et al: Human monocyte response to particulate biomaterials generated in vivo and in vitro. J Orthop Res 13:792-801, 1995
65. Rogers SD, Howie DW, Graves SE, et al: In vitro human monocyte response to wear particles of titanium alloy containing vanadium or niobium. J Bone Joint Surg Br 79:311-315, 1997
66. Shanbhag AS, Jacobs JJ, Black J, et al: Effects of particles on fibroblast proliferation and bone resorption in vitro. Clin Orthop 342:205-217, 1997
67. Ingham E, Green TR, Stone MH, et al: Production of TNF-α and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials 21:1005-1013, 2000
68. Gelb H, Schumacher HR, Cuckler J, et al: In vivo inflammatory response to polymethylmethacrylate particulate debris: Effect of size, morphology, and surface area. J Orthop Res 12:83-92, 1994
69. Campbell PA, Dorey F, McKellop HA, et al: Morphological characterization of UHMWPE particles from total hips with alumina ceramic and cobalt femoral heads. Transactions of the Society for Biomaterials 18: 308, 1995
70. Lazarus MD, Cuckler JM, Mitchell J, et al: Biocompatibility of PMMA with and without barium sulfate in the rat subcutaneous air pouch model, in St John K (ed): Particulate debris from medical implants. Philadelphia, PA, American Society for Testing and Materials, 1991
71. Goodman SB, Huie P, Song Y, et al: Loosening and osteolysis of cemented joint arthroplasties. Clin Orthop 337:149-163, 1997
72. Wright T, Goodman S: Implant wear in total joint replacement: Clinical and biologic issues, material and design consideration. Rosemont, IL, American Academy, 2001, pp 71-85
73. Goodman SB, Knoblich G, O'Connor M, et al: Heterogenicity in cellular and cytokine profiles from multiple samples of tissue surrounding revised hip prostheses. J Biomed Mater Res 31:421-428, 1996
74. Athanasou NA: Cellular biology of bone-resorbing cells. J Bone Joint Surg Am 78:1096-1112, 1996
75. Pandey R, Quinn J, Joyner C, et al: Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells. Ann Rheum Dis 55:388-395, 1996
76. Rifkin BR, Gay CV: Biology and physiology of the osteoclast. Boca Raton, FL, CRC Press, 1992
77. Amstutz HC, Campbell P, Kossovsky N, et al: Mechanism and clinical significance of wear debris-induced osteolysis. Clin Orthop 276:7-18, 1992
78. Lennox DW, Schofield BH, McDonald DF, et al: A histologic comparison of aseptic loosening of cemented, press-fit, and biologic ingrowth prostheses. Clin Orthop 255:171-191, 1987
79. Quinn J, Joyner C, Triffitt JT, et al: Polymethacrylate-induced inflammatory macrophages resorb bone. J Bone Joint Surg Br 74:652-658, 1992
80. Williams RP, McQueen DA: A histopathologic study of late aseptic loosening of cemented total hip prostheses. Clin Orthop 275:174-179, 1992
81. Glant TT, Jacobs JJ, Molnar G, et al: Bone resorption activity of particulate-stimulated macrophages. J Bone Miner Res 8:1071-1079, 1993
82. Konttinen YT, Xu J-W, Pätiälä H, et al: Cytokines in aseptic loosening of total hip replacement. Current Orthopaedics 11:40-47, 1997
83. Ferguson GM, Watanabe S, Georgescu HI, et al: The synovial production of collagenase and chondrocyte activating factors in response to cobalt. J Orthop Res 6:525-530, 1988
84. Yao J, Glant TT, Lark MW, et al: The potential role of fibroblasts in periprosthetic osteolysis: Fibroblast response to titanium particles. J Bone Miner Res 10:1417-1427, 1995
85. Murray DW, Rushton N: Macrophages stimulate bone resorption when they phagocytose particles. J Bone Joint Surg Br 72:988-992, 1991
86. Felix R, Genolet CL, Lowik C, et al: Cytokine production by calvariae of osteopetrotic mice. Bone 17:5-9, 1995
87. Pollice PF, Silverton SF, Horowitz SM: Polymethacrylate-stimulated macrophages increase rat osteoclast precursor recruitment through their effect on osteoblasts in vitro. J Orthop Res 13:325-334, 1995
88. Al Saffar N, Revell RP: Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: A potential role in osteolysis. Br J Rheumatol 33:309-316, 1994
89. Al-Saffar N, Mah JT, Kadoya Y, et al: Neovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants. Ann Rheum Dis 54:201-208, 1995
90. Santavirta S, Nordstrom D, Metsarinne K, et al: Biocompatibility of polyethylene and host response to loosening of cementless total hip replacement. Clin Orthop 297:100-110, 1993
91. Wang JY, Wicklund BH, Gustilo RB, et al: Titanium, chromium and cobalt ions modulate the release of bone-associated cytokines by human monocytes/macrophages in vitro. Biomaterials 17:2233-2240, 1996
92. Sabokar A, Rushton N: Role of inflammatory mediators and adhesion molecules in the pathogenesis of aseptic loosening in total hip arthroplasties. J Arthroplasty 10: 810-816, 1995
93. Neale SD, Sabokbar A, Howie DW, et al: Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption. J Orthop Res 17:686-694, 1999
94. Xu JW, Konttinen YT, Waris V, et al: Macrophage colony-stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissue in the aseptic loosening of total hip replacement (THR). Clin Rheumatol 16:243-248, 1997
95. Konttinen YT, Waris V, Xu JW, et al: Transforming growth factor-β 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty. J Rheumatol 24:694-701, 1997
96. Xu JW, Konttinen YT, Li TF, et al: Production of platelet-derived growth factor in aseptic loosening of total hip replacement. Rheumatol Int 17:215-221, 1998
97. Horowitz SM, Prudon MA: Mechanisms of cellular recruitment in aseptic loosening of prosthetic joint implants. Calcif Tissue Int 57:301-305, 1995
98. Algan SM, Purdon M, Horowitz SM: Role of tumor necrosis factor alpha in particulate-induced bone resorption. J Orthop Res 14:30-35, 1996
99. Horowitz SM, Luchetti WT, Gonzales JB, et al: The effects of cobalt chromium upon macrophages. J Biomed Mater Res 41:468-473, 1998
100. Lacey DL, Tan HL, Lu J, et al: Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol 157:435-448, 2000
101. Lacey DL, Timms E, Tan HL, et al: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176, 1998
102. Yasuda H, Shima N, Nakagawa N, et al: A novel molecular mechanism modulating osteoclast differentiation and function. Bone 25:109-113, 1999
103. Yasuda H, Shima N, Nakagawa N, et al: Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95:3597-3602, 1998
104. Xu JW, Konttinen YT, Lassus J, et al: Tumor necrosis factor-alpha (TNF-α) in loosening of total hip replacement (THR). Clin Exp Rheumatol 14:643-648, 1996
105. Haynes DR, Crotti TN, Potter AE, et al: The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg Br 83:902-911, 2001
106. Lam J, Takeshita S, Barker JE, et al: TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481-1488, 2000
107. Vermes C, Roebuck KA, Chandrasekaran R, et al: Particulate wear debris activates protein tyrosine kinases and nuclear factor κB, which down-regulates type I collagen synthesis in human osteoblasts. J Bone Miner Res 15:1756-1765, 2000
108. Wuyts W, Van Wesenbeeck L, Morales-Piga A, et al: Evaluation of the role of RANK and OPG genes in Paget's disease of bone. Bone 28:101-107, 2001
109. Oyajobi BO, Anderson DM, Traianedes K, et al: Therapeutic efficacy of a soluble receptor activator of nuclear factor κB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy. Cancer Res 61: 2572-2578, 2001
110. Guise TA: Molecular mechanisms of osteolytic bone metastases. Cancer 88:2892-2898, 2000 (suppl)
111. Atkins GJ, Bouralexis S, Haynes DR, et al: Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. Bone 28:370-377, 2001
112. Schwarz EM, Lu AP, Goater JJ, et al: Tumor necrosis factor-α/nuclear transcription factor-κB signaling in periprosthetic osteolysis. J Orthop Res 18:472-480, 2000
113. Udagawa N, Takahashi N, Yasuda H, et al: Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478-3484, 2000
114. Anthony PP, Gie GA, Howie CR, et al: Localised endosteal bone lysis in relation to the femoral components of cemented total hip arthroplasties. J Bone Joint Surg Br 72:971-979, 1990
115. Aspenberg P, Van DV: Fluid pressure may cause periprosthetic osteolysis. Particles are not the only thing. Acta Orthop Scand 69:1-4, 1998
116. Van der Vis H, Aspenberg P, Marti RK, et al: Fluid pressure causes bone resorption in a rabbit model of prosthetic loosening. Clin Orthop 350:201-208, 1998
117. Garvin KL, Hanssen AD: Infection after total hip arthroplasty: Past, present, and future. J Bone Joint Surg Am 77:1576-1588, 1995
118. Hoeffel DP, Hinrichs SH, Garvin KL: Molecular diagnostics for the detection of musculoskeletal infection. Clin Orthop 360:37-46, 1999
119. Glenn JV, O'Hagan S, Clingen-Vance G, et al: Serodiagnosis in anaerobic periprosthetic hip infection. Anaerobe 2000: An International Congress of the Confederation of Anaerobic Societies, Manchester, England, 2000, p 206
120. Aspenberg P, Herbertsson P: Periprosthetic bone resorption: Particles versus movement. J Bone Joint Surg Am 78:641-646, 1996
121. Goodman SB: The effects of micromotion and particulate materials on tissue differentiation: Bone chamber studies in rabbits. Acta Orthop Scand 258:1-43, 1994 (suppl)
122. Karrholm J, Malchau H, Snorrason F, et al: Micromotion of femoral stems in total hip arthroplasty: A randomized study of cemented, hydroxypatite-coated and porous-coated stem with roentgen stereophotometric analysis. J Bone Joint Surg Am 76:1692-1705, 1994
123. Takagi M: Neutral proteinases and their inhibitors in the loosening of total hip prosthesis. Acta Orthop Scand 67:1-29, 1996 (suppl 271)
124. Sabokbar A, Fujikawa Y, Neale S, et al: Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis 56:414-420, 1997
125. Wright T, Goodman S: Implant wear in total joint replacement: Clinical and biologic issues, material and design consideration. Rosemont, IL, American Academy, 2001, pp 34-37
126. Evans EM, Freeman MAR, Miller AJ, et al: Metal sensitivity as a cause of bone necrosis and loosening of the prosthesis in total joint replacement. J Bone Joint Surg Br 56:626-642, 1974
127. Lalor PA, Revell PA, Gray AB, et al: Sensitivity to titanium (a cause of implant failure?). J Bone Joint Surg Br 73:25-28, 1991
128. Merritt K, Rodrigo JJ: Immune response to synthetic materials sensitization of patients receiving orthopaedic implants. Clin Orthop 326:71-79, 1996
129. Fife MS, Fisher SA, John S, et al: Multipoint linkage analysis of a candidate gene locus in rheumatoid arthritis demonstrates significant evidence of linkage and association with the corticotropin-releasing hormone genomic region. Arthritis Rheum 43:1673-1678, 2000
130. Mattey DL, Hajeer AH, Dababneh A, et al: Association of giant cell arthritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum 43:1749-1755, 2000
131. Nieto A, Caliz R, Pascual M, et al: Involvement of FcY reception IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum 43:735-739, 2000
132. Shibue T, Tsuchiya N, Komata T, et al: Tumor necrosis factor a 5′-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis. Arthritis Rheum 43: 2403-2408, 2000
133. Boehnke M: A look at linkage disequilibrium. Nat Genet 25:246-247, 2000
134. Goldring SR, Wojno WC, Schiller AL, et al: In patients with rheumatoid arthritis the tissue reaction associated with loosened total knee replacements exhibits features of a rheumatoid synovium. J Orthop Rheum 1:9-21, 1988
135. Wilkinson JM, Wilson AG, Stockley I, et al: Promoter polymorphism in the TNF-α gene and risk of osteolysis after THA. Transactions of the Orthopedic Research Society 48th Annual Meeting, poster 339, San Francisco, CA, 2002
136. Cho DR, Hong CY, Baran GR, et al: Adsorbed endotoxin mediates differential effects on particle-induced stimulation of cytokine and chemokine release. Trans Orthop Res Soc 24:6, 1999
137. Daniels AU, Barnes FH, Charlebois SJ, et al: Macrophage cytokine response to particles and lipopolysaccharide in vitro. J Biomed Mater Res 49:469-478, 2000
138. Hitchins VM, Merritt K: Decontaminating particles exposed to bacterial endotoxin (LPS). J Biomed Mater Res 46:434-437, 1999
139. Akisue T, Bauer T, Farver C: The effect of particle wear debris on nuclear factor κ B activation in differentiated THP-1 cells. Trans Orthop Res Soc 25:594, 2000
140. Aspenberg P: Adherent endotoxins are necessary for particle-induced bone resorption in a rat model. Trans Orthop Res Soc 25:704, 2000
141. Abu-Amer Y, Ross FP, Edwards J, et al: Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100:1557-1565, 1997
142. Dean DD, Schwartz Z, Liu Y, et al: The effect of ultrahigh molecular-weight polyethylene wear debris on MG63 osteosarcoma cells in vitro. J Bone Joint Surg Am 81:452-461, 1999
143. Dean DD, Schwartz Z, Blanchard CR, et al: Ultrahigh molecular weight polyethylene (UHMWPE) particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells. J Orthop Res 17:9-17, 1999
144. Lohmann CH, Schwartz Z, Koster G, et al: Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition. Biomaterials 21:551-561, 2000
145. Garnero P, Sornay-Rendu E, Claustrat B, et al: Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. J Bone Miner Res 15:1526-1536, 2000
146. Karpf DB, Shapiro DR, Seeman E, et al: Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA 277:1159-1164, 1997
147. Liberman UA, Weiss SR, Broll J, et al: Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437-1443, 1995
148. Ravin P, Clemmesen B, Christiansen C: Biochemical markets can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group. Bone 24:237-244, 1999
149. Black DM, Thompson DE, Bauer DC, et al: Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial. FIT Research Group. J Clin Endrocrinol Metab 85:4118-4124, 2000
150. Shanbhag AS, Hasselman CT, Rubash HE: The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop 344:33-43, 1997
151. Illgen R, Shanbhag AS, Deshmukh AV, et al: In vitro analysis of novel, clinically relevant osteoclast inhibitors. Trans Orthop Res 23:134, 2001
152. Bergstrom JD, Bostedor RG, Masarachia PJ, et al: Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys 373:231-241, 2000
153. Sundquist K, Lakkakorpi P, Wallmark B, et al: Inhibition of osteoclast proton transport by Bafilomycin A1 abolishes bone resorption. Biochem Biophys Res Commun 168:309-313, 1990
154. Ferrara N, Houck KA, Jakeman LB, et al: The VEGF family of polypeptides. J Cell Biochem 47:211-218, 1991
155. Zhang X, Morham SG, Langenbach R, et al: Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis. J Bone Miner Res 16:660-670, 2001
156. Pollice PF, Rosier RN, Looney RJ, et al: Oral pentoxifylline inhibits release of tumor necrosis factor-α from human peripheral blood monocytes: A potential treatment for aseptic loosening of total joint components. J Bone Joint Surg Am 83:1057-1061, 2001
157. Childs LM, Goater JJ, O'Keefe RJ, et al: Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 16:338-347, 2001
158. Childs LM, Goater J, O'Keefe RJ, et al: Effect of anti-tumor necrosis factor-a gene therapy on wear debris-induced osteolysis. J Bone Joint Surg Am 83:1789-1797, 2001
159. Merkel KD, Erdmann JM, McHugh KP, et al: Tumor necrosis factor-α mediates orthopedic implant osteolysis. Am J Pathol 154:203-210, 1999
160. Schwarz EM, Looney RJ, O'Keefe RJ: Anti-TNF-α therapy as a clinical intervention for periprosthetic osteolysis. Arthritis Res 2:165-168, 2000
161. Watts NB: Clinical utility of biochemical markers of bone remodeling. Clin Chem 45:10-68, 1999
162. Greenspan SL, Rosen HN, Parker RA: Early changes in serum N-telopeptide and C-telopeptide cross-linked collage type 1 predict long-term response to alendronate therapy in elderly women. J Clin Endocrinol Metab 85:3537-3540, 2000
163. Antoniou J, Huk O, Zukor D, et al: Collagen crosslinked N-telopeptides as markers for evaluating particulate osteolysis: A preliminary study. J Orthop Res 18:64-67, 2000
164. Qureshi AA, Virdi AS, Didonna ML, et al: Implant design effects markers of bone resorption and formation in total joint replacement. J Bone Miner Res 17: 800-807, 2002
165. Illgen R, Fadel A, Squire M, et al: A novel method of identifying osteolysis utilizing serum markers of bone formation and resorption. Transactions of the Othopedic Research Society 48th Annual Meeting, poster 511, San Francisco, CA, 2002